United Immunity, a clinical stage biotechnology company, has raised a total of ¥2.2 billion in private financing, comprising ...

Thermo Fisher Scientific has announced the launch of Gibco™ CHO-K1 Catalog Panel, a cGMP-ready portfolio of basal and feed ...

A new Digestive Health Centre has opened at the Woodlands Hospital in Singapore. The Centre brings together comprehensive ...

The European Commission has granted marketing authorisation for NEZGLYAL, the first pharmacological treatment for cerebral ...

Deep Origin’s PREDICTS consortium has deployed AI-based ADMET safety models across four drug discovery organisations, with wet-lab results feeding back into the system to improve future predictions.

Germfree has appointed Adam Simon as CFO and Geoffrey Schwartz as CCO as it strengthens its financial, operational and commercial capabilities across life sciences, healthcare and biocontainment.

Matthias Skillecorn of Johnson & Johnson discusses how APEC can support earlier diagnosis, biomarker testing, treatment access and stronger regional collaboration to improve lung cancer outcomes ...

Novotech, the global full-service clinical research organisation (CRO) and scientific advisory company, has reached agreement ...

AIMD Inc., a Korean medical technology company specialising in AI-powered emergency care, has announced the global expansion ...

WuXi XDC Cayman Inc., a leading global Contract Research, Development and Manufacturing Organisation (CRDMO) focused on the ...

Romsons Group, one of India’s leading brands in the medical devices and hygiene products sector, has announced the successful ...

An Australian-first cancer research facility that will allow scientists to examine individual cancer and immune cells in ...